MY ACCOUNT | NEWSLETTER |

Penn Vet Announces Interim Leadership for the Department of Clinical Sciences and Advanced Medicine, and Ryan Hospital


he University of Pennsylvania School of Veterinary Medicine (Penn Vet) has announced two interim leadership appointments to lead its academic and clinical programs. Susan W. Volk, VMD, PhD, DACVS, has been named interim chair of the Department of Clinical Sciences and Advanced Medicine, and Deborah C. Silverstein, DVM, DACVECC, has been appointed interim associate dean and Ryan Hospital director.

In their new roles, Drs. Volk and Silverstein will work closely together to support Penn Vet’s integrated missions of patient care, education, and research and to strengthen collaboration between the School’s academic departments and clinical operations.

“Drs. Volk and Silverstein are exceptional leaders whose combined expertise in translational research and clinical medicine will help advance Penn Vet during this important period,” said Andrew M. Hoffman, DVM, DVSc, DACVIM, Penn Vet’s Gilbert S. Kahn Dean of Veterinary Medicine. “Their partnership reflects the strength of our faculty and our commitment to advancing veterinary medicine through collaboration and innovation.”

An internationally recognized veterinary surgeon-scientist and board-certified Diplomate of the American College of Veterinary Surgeons, Volk earned her VMD and PhD through the University of Pennsylvania’s Veterinary Medical Scientist Training Program. A faculty member since 2007, her research focuses on the role of the extracellular matrix in wound healing, fibrosis, and cancer and is supported by multiple NIH grants and foundation awards. She currently serves as the Corinne R. and Henry Bower Professor of Surgery and is widely recognized for her mentorship and cross-disciplinary collaborations. Volk is a member of the Editorial Board of Wound Repair and Regeneration and serves on the Board of Directors for both the Wound Healing Society and the North American Veterinary Regenerative Medicine Association. In 2025, she was appointed president of the Wound Healing Society.

Silverstein is a professor of Emergency and Critical Care and the section chief of Emergency and Critical Care at Ryan Hospital. She received her DVM from the University of Georgia, where she also completed a small-animal rotating internship, followed by a residency in small-animal emergency and critical care at the University of California, Davis. A leader in her field, Silverstein is known for her expertise in managing critically ill patients and for her commitment to advancing emergency and critical care medicine. Her publications focus on the diagnosis and treatment of shock states, resuscitation of unstable patients, and changes in the microcirculation in acutely ill patients. She has contributed extensively to the field’s scholarship as co-editor of leading textbooks, including Small Animal Critical Care Medicine and Textbook of Small Animal Emergency Medicine. Silverstein frequently presents on small-animal critical care, and her expertise has been featured in media outlets such as The New York Times, PBS NewsHour, and NBC News.

As interim hospital director, Silverstein will oversee hospital operations and work with clinical and administrative leadership to ensure continued excellence in patient care. As interim chair, Volk will lead the Department of Clinical Sciences and Advanced Medicine, supporting faculty, trainees, and research programs. Together, they will help align Penn Vet’s academic and clinical priorities, foster collaboration across disciplines, and advance the School’s impact in veterinary medicine.

These interim appointments follow leadership transitions, including Brady Beale’s departure as hospital director to lead the American Animal Hospital Association (AAHA), and Mark Oyama’s planned retirement as department chair following a one-year terminal sabbatical.


Author: Martin J. Hackett

Source: https://www.vet.upenn.edu/

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Parnell Launches nixiFLOR® - First FDA-Approved Generic Florfenicol + Flunixin Combination for BRD

Like0
Dislike0

Comparison of two host cell range variants of feline immunodeficiency virus

Like0
Dislike0

Canine babesiosis: a perspective on clinical complications, biomarkers, and treatment

Like0
Dislike0

The use of growth promoters in swine nutrition: Problems and perspectives concerning public health and swine production

Like0
Dislike0

Breakthrough takes big step toward safe, reversible male contraception

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top